Ian James

3.5k total citations
72 papers, 2.6k citations indexed

About

Ian James is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Ian James has authored 72 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 16 papers in Radiology, Nuclear Medicine and Imaging and 14 papers in Molecular Biology. Recurrent topics in Ian James's work include Monoclonal and Polyclonal Antibodies Research (13 papers), HIV Research and Treatment (13 papers) and HER2/EGFR in Cancer Research (7 papers). Ian James is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (13 papers), HIV Research and Treatment (13 papers) and HER2/EGFR in Cancer Research (7 papers). Ian James collaborates with scholars based in United Kingdom, United States and Germany. Ian James's co-authors include Marilyn Lewis, Elna van der Ryst, David I. Perrett, Anton Pozniak, Mike Youle, T.M. Jenkins, Hendrik Neubert, P. Richard Harrigan, Jayvant Heera and Hernán Valdez and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Ian James

71 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ian James United Kingdom 28 969 759 671 468 375 72 2.6k
Wolf K. Hofmann Germany 20 849 0.9× 517 0.7× 1.8k 2.6× 459 1.0× 621 1.7× 41 3.4k
Paul Bowness United Kingdom 45 188 0.2× 277 0.4× 1.2k 1.8× 443 0.9× 3.6k 9.5× 131 6.0k
Yujie Liu China 20 291 0.3× 191 0.3× 865 1.3× 499 1.1× 1.4k 3.6× 118 3.0k
Iyadh Douagi Sweden 30 292 0.3× 298 0.4× 891 1.3× 245 0.5× 1.1k 3.0× 56 2.7k
Anja Wuyts Belgium 30 244 0.3× 183 0.2× 975 1.5× 2.1k 4.6× 2.2k 5.8× 42 4.5k
Qigui Yu United States 26 359 0.4× 269 0.4× 407 0.6× 151 0.3× 588 1.6× 75 1.6k
Gary P. Sims United States 23 85 0.1× 216 0.3× 937 1.4× 474 1.0× 2.5k 6.7× 44 4.9k
Marcus O. Muench United States 38 144 0.1× 736 1.0× 1.8k 2.7× 409 0.9× 1.5k 3.9× 121 5.2k
Bertil Glader United States 30 160 0.2× 358 0.5× 2.2k 3.2× 710 1.5× 338 0.9× 131 4.6k
Charles J. Parker United States 36 179 0.2× 138 0.2× 485 0.7× 82 0.2× 1.8k 4.9× 99 3.4k

Countries citing papers authored by Ian James

Since Specialization
Citations

This map shows the geographic impact of Ian James's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian James with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian James more than expected).

Fields of papers citing papers by Ian James

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian James. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian James. The network helps show where Ian James may publish in the future.

Co-authorship network of co-authors of Ian James

This figure shows the co-authorship network connecting the top 25 collaborators of Ian James. A scholar is included among the top collaborators of Ian James based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian James. Ian James is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Jacob, Wolfgang, Ian James, Max Hasmann, & Maja Weisser. (2018). Clinical development of HER3-targeting monoclonal antibodies: Perils and progress. Cancer Treatment Reviews. 68. 111–123. 43 indexed citations
3.
Bensch, Frederike, Laetitia E. Lamberts, Annelies Jorritsma‐Smit, et al.. (2017). 89Zr-Lumretuzumab PET Imaging before and during HER3 Antibody Lumretuzumab Treatment in Patients with Solid Tumors. Clinical Cancer Research. 23(20). 6128–6137. 57 indexed citations
4.
Collins, Denis M., Wolfgang Jacob, Juan Miguel Cejalvo, et al.. (2017). Direct estrogen receptor (ER) / HER family crosstalk mediating sensitivity to lumretuzumab and pertuzumab in ER+ breast cancer. PLoS ONE. 12(5). e0177331–e0177331. 39 indexed citations
5.
Han, Ji‐Youn, Kun Young Lim, Jin Young Kim, et al.. (2017). P3.02c-006 EGFR and HER3 Inhibition - A Novel Therapy for Invasive Mucinous Non-Small Cell Lung Cancer Harboring an NRG1 Fusion Gene. Journal of Thoracic Oncology. 12(1). S1274–S1275. 5 indexed citations
6.
7.
Swenson, Luke C., Theresa Mo, Winnie Dong, et al.. (2011). Deep V3 Sequencing for HIV Type 1 Tropism in Treatment-Naive Patients: A Reanalysis of the MERIT Trial of Maraviroc. Clinical Infectious Diseases. 53(7). 732–742. 79 indexed citations
8.
Swenson, Luke C., Winnie Dong, Xiaolin Zhong, et al.. (2010). Deep Sequencing to Infer HIV-1 Co-Receptor Usage: Application to Three Clinical Trials of Maraviroc in Treatment-Experienced Patients. The Journal of Infectious Diseases. 203(2). 237–245. 119 indexed citations
9.
Able, Sarah, Paul Griffin, Ian James, et al.. (2009). Chapter 2 CCR5 Pharmacology Methodologies and Associated Applications. Methods in enzymology on CD-ROM/Methods in enzymology. 460. 17–55. 13 indexed citations
10.
Archer, John, Michael Braverman, Bruce E. Taillon, et al.. (2009). Detection of low-frequency pretherapy chemokine (CXC motif) receptor 4 (CXCR4)-using HIV-1 with ultra-deep pyrosequencing. AIDS. 23(10). 1209–1218. 98 indexed citations
11.
12.
Fätkenheuer, Gerd, Anton Pozniak, Margaret Johnson, et al.. (2005). Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1. Nature Medicine. 11(11). 1170–1172. 386 indexed citations
13.
Walker, John B., Bernadette Hughes, Ian James, et al.. (2003). Stabilization Versus Inhibition of TAFIa by Competitive Inhibitors in Vitro. Journal of Biological Chemistry. 278(11). 8913–8921. 51 indexed citations
14.
15.
Walne, Amanda J., Paul J. Jenkins, Ian James, & P.N. Plowman. (1997). Pyridinium crosslinks in the monitoring of patients with bone metastases from carcinoma of the breast. Clinical Oncology. 9(1). 30–34. 5 indexed citations
16.
James, Ian, et al.. (1993). Assay of pyridinium crosslinks in serum using narrow-bore ion-paired reversed-phase high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 612(1). 41–48. 25 indexed citations
17.
Spector, T. D., Ian James, G. M. Hall, et al.. (1993). Increased levels of urinary collagen crosslinks in females with rheumatoid arthritis. Clinical Rheumatology. 12(2). 240–244. 24 indexed citations
18.
Houston, Stephen, et al.. (1992). Preliminary results of the use of urinary excretion of pyridinium crosslinks for monitoring metastatic bone disease. British Journal of Cancer. 65(5). 766–768. 61 indexed citations
19.
Thompson, P. W., T. D. Spector, Ian James, Elizabeth Henderson, & Deborah Hart. (1992). URINARY COLLAGEN CROSSLINKS REFLECT THE RADIOGRAPHIC SEVERITY OF KNEE OSTEOARTHRITIS. Lara D. Veeken. 31(11). 759–761. 41 indexed citations
20.
Thompson, Paul, et al.. (1990). Evaluation of a simple method for the measurement of cytidine deaminase in serum and comparison with a reference method. Clinica Chimica Acta. 192(1). 55–59. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wolf K. Hofmann Breakdown of academic impact, for papers by Paul Bowness Breakdown of academic impact, for papers by Yujie Liu Breakdown of academic impact, for papers by Iyadh Douagi Breakdown of academic impact, for papers by Anja Wuyts Breakdown of academic impact, for papers by Qigui Yu Breakdown of academic impact, for papers by Gary P. Sims Breakdown of academic impact, for papers by Marcus O. Muench Breakdown of academic impact, for papers by Bertil Glader Breakdown of academic impact, for papers by Charles J. Parker
Rankless by CCL
2026